References
- Poe RH, Marcus HR, Emerson GL. Lung abscess due to Pseudomonas cepacia. Am Rev Respir Dis 1977;115:861-5
- Snell GI, Hoyos A, Krajden M, Winton T, Maurer JR. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993;103:466-71 https://doi.org/10.1378/chest.103.2.466
- Kim TY, Young HM, Hwang JK, Cho YM, Park YJ, Park DJ, et al. A case of acute suppurative thyroiditis as a complication of acupuncture in patient with a benign thyroid nodule. J Korean Soc Endocrinol 2002;17:576-82
- Speert DP. Advances in Burkholderia cepacia complex. Pediatr Respri Rev 2002;3:230-5 https://doi.org/10.1016/S1526-0542(02)00185-9
- Langley R, Kenna DT, Vandamme P, Ure R, Govan JR. Lysogeny and bacteriophage host range within the Burkholderia cepacia complex. J Med Microbiol 2003;52:483-90 https://doi.org/10.1099/jmm.0.05099-0
- Maningo E, Watanakunakorn C. Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J Infect 1995;31:89-92 https://doi.org/10.1016/S0163-4453(95)91985-6
- Balkhy HH, Cunningham G, Francis C, Almuneef MA, Stevens G, Akkad N, et al. A national guard outbreak of Burkholderia cepacia infection and colonization secondary to intrinsic contamination of albuterol nebulization solution. Am J Infect Control 2005;33:182-8 https://doi.org/10.1016/j.ajic.2005.01.001
- Mohr CD, Tomich M, Herfst CA. Cellular aspects of Burkholderia cepacia infection. Microbes Infect 2001;3:425-35 https://doi.org/10.1016/S1286-4579(01)01389-2
- Sader HS, Jones RN. Antimicrobial susceptibility of uncommonly isolated non-enteric gram-negative bacilli. Int J Antimicrob Agents 2005;25:95-109 https://doi.org/10.1016/j.ijantimicag.2004.10.002
- Lu DC, Change SC, Chen YC, Luh KT, Hsieh WC. In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolates from blood. Diagn Microbiol Infect Dis 1997;28:187-91.pT https://doi.org/10.1016/S0732-8893(97)00069-2
-
Isenberg HD, Alperstein P, France K. In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with
$\beta$ -lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia. Diagn Microbiol Infect Dis 1999;33:81-6 https://doi.org/10.1016/S0732-8893(98)00126-6 - Canton R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, et al. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin Microbiol Infect 2005;11:690-703 https://doi.org/10.1111/j.1469-0691.2005.01217.x